Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,116
Recruiting: 10,894
Ph III recruiting: 1,280
Growth YoY: +12%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,163)

clinicaltrialsPublishedShowing 1,051–1,100 of 1,399 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02065466	Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases	withdrawn	Phase 1 / Phase 2	0	University of ArizonaOTHER	1	Apr 21, 2016	clinicaltrials
NCT02119728	Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity	withdrawn	Phase 2	0	Roswell Park Cancer InstituteOTHER	1	Apr 21, 2016	clinicaltrials